Literature DB >> 12130767

Parasitology. Drugs to combat tropical protozoan parasites.

Michael H Gelb1, Wim G J Hol.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12130767     DOI: 10.1126/science.1073126

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  13 in total

Review 1.  Secondary loss of chloroplasts in trypanosomes.

Authors:  William Martin; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

2.  In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.

Authors:  Alisson L Matsuo; Luis S Silva; Ana C Torrecilhas; Bruno S Pascoalino; Thiago C Ramos; Elaine G Rodrigues; Sergio Schenkman; Antonio C F Caires; Luiz R Travassos
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

3.  Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discovery.

Authors:  James M Kraus; Hari Babu Tatipaka; Sarah A McGuffin; Naveen Kumar Chennamaneni; Mandana Karimi; Jenifer Arif; Christophe L M J Verlinde; Frederick S Buckner; Michael H Gelb
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

4.  Structures and bioactivities of dihydrochalcones from Metrodorea stipularis.

Authors:  Marcela C de Melo Burger; João Batista Fernandes; Maria F das Graças Fernandes da Silva; Aster Escalante; Jacques Prudhomme; Karine G Le Roch; Mario A Izidoro; Paulo C Vieira
Journal:  J Nat Prod       Date:  2014-11-06       Impact factor: 4.050

5.  New chemical scaffolds for human african trypanosomiasis lead discovery from a screen of tyrosine kinase inhibitor drugs.

Authors:  Ranjan Behera; Sarah M Thomas; Kojo Mensa-Wilmot
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

6.  Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors.

Authors:  Jean Jerley N Silva; Wander R Pavanelli; José Clayston M Pereira; João S Silva; Douglas W Franco
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

7.  2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities.

Authors:  Boris Rodenko; Alida M van der Burg; Martin J Wanner; Marcel Kaiser; Reto Brun; Matthew Gould; Harry P de Koning; Gerrit-Jan Koomen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

8.  In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.

Authors:  J J N Silva; A L Osakabe; W R Pavanelli; J S Silva; D W Franco
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

9.  Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas' disease treatment.

Authors:  Priscila V S Z Capriles; Ana C R Guimarães; Thomas D Otto; Antonio B Miranda; Laurent E Dardenne; Wim M Degrave
Journal:  BMC Genomics       Date:  2010-10-29       Impact factor: 3.969

10.  Synthesis and evaluation of α-thymidine analogues as novel antimalarials.

Authors:  Huaqing Cui; Juana Carrero-Lérida; Ana P G Silva; Jean L Whittingham; James A Brannigan; Luis M Ruiz-Pérez; Kevin D Read; Keith S Wilson; Dolores González-Pacanowska; Ian H Gilbert
Journal:  J Med Chem       Date:  2012-12-14       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.